نتائج البحث - David Lucas
- يعرض 1 - 20 نتائج من 45
- اذهب إلى الاصفحة التالية
-
1
-
2
Seafarers’ Occupational Noise Exposure and Cardiovascular Risk. Comments to Bolm-Audorff, U.; et al. Occupational Noise and Hypertension Risk: A Systematic Review and Meta-Analysis... حسب David, Lucas, Brice, Loddé, Richard, Pougnet, Jean Dominique, Dewitte, Dominique, Jégaden
منشور في 2021نص -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction حسب John C. Byrd, Shinichi Kitada, Ian W. Flinn, Jennifer L. Aron, Michael Pearson, David Lucas, John C. Reed
منشور في 2002Artigo -
11
-
12
Methylation and Silencing of Protein Tyrosine Phosphatase Receptor Type O in Chronic Lymphocytic Leukemia حسب Tasneem Motiwala, Sarmila Majumder, Huban Kutay, David S. Smith, Donna Neuberg, David Lucas, John C. Byrd, Michael R. Grever, Samson T. Jacob
منشور في 2007Artigo -
13
Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia حسب Amy J. Johnson, David Lucas, Natarajan Muthusamy, Lisa L. Smith, Ryan B. Edwards, Michael De Lay, Carlo M. Croce, Michael R. Grever, John C. Byrd
منشور في 2006Artigo -
14
Serious pulmonary toxicity in patients with Hodgkin’s lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism... حسب Kristie A. Blum, Sin‐Ho Jung, Jeffrey L. Johnson, Thomas S. Lin, Eric D. Hsi, David Lucas, John C. Byrd, Bruce D. Cheson, Nancy L. Bartlett
منشور في 2010Artigo -
15
Daunorubicin‐Loaded DNA Origami Nanostructures Circumvent Drug‐Resistance Mechanisms in a Leukemia Model حسب Patrick D. Halley, Christopher R. Lucas, Emily M. McWilliams, Matthew J. Webber, Randy A. Patton, Cömert Kural, David Lucas, John C. Byrd, Carlos E. Castro
منشور في 2015Artigo -
16
Select High-Risk Genetic Features Predict Earlier Progression Following Chemoimmunotherapy With Fludarabine and Rituximab in Chronic Lymphocytic Leukemia: Justification for Risk-Ad... حسب John C. Byrd, John G. Gribben, Bercedis L. Peterson, Michael R. Grever, Gerard Lozanski, David Lucas, Ben Lampson, Richard A. Larson, Michael A. Caligiuri, Nyla A. Heerema
منشور في 2005Artigo -
17
Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL حسب Shih-Shih Chen, Rainer Claus, David Lucas, Lianbo Yu, Qian Jiang, Amy S. Ruppert, Derek A. West, Katie Williams, Amy J. Johnson, Fred Sablitzky, Christoph Plass, John C. Byrd
منشور في 2010Artigo -
18
Pentostatin in Steroid-Refractory Acute Graft-Versus-Host Disease حسب Javier Bolaños‐Meade, David A. Jacobsohn, Jeffrey Margolis, Adam Ogden, M. Guillaume Wientjes, John C. Byrd, David Lucas, Viki Anders, Michele Phelps, Michael R. Grever, Georgia B. Vogelsang
منشور في 2005Artigo -
19
As dificuldades na abordagem integral à saúde LGBTQIA+ حسب David Lucas Viana Garcia, Sofia Maria Brito Cal Muinhos, Palloma Linhares de Almeida, Ravenna Gomes Oliveira de Alencar, E Silva, Yasmim Farias de Miranda, Layza de Souza Chaves Deininger
منشور في 2024Artigo -
20
Persistence of<i>DNMT3A</i>R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia حسب Bhavana Bhatnagar, Ann‐Kathrin Eisfeld, Deedra Nicolet, Krzysztof Mrózek, James S. Blachly, Shelley Orwick, David Lucas, Jessica Kohlschmidt, William Blum, Jonathan E. Kolitz, Richard M. Stone, Clara D. Bloomfield, John C. Byrd
منشور في 2016Artigo
أدوات البحث:
موضوعات ذات صلة
Biology
Leukemia
Medicine
Chronic lymphocytic leukemia
Internal medicine
Cancer research
Immunology
Biochemistry
Gene
Genetics
Chemotherapy
Oncology
Pharmacology
Gastroenterology
In vivo
Lymphoma
Biotechnology
Chemistry
Cyclophosphamide
DNA methylation
Gene expression
In vitro
Apoptosis
Fludarabine
Computational biology
Methylation
Rituximab
Toxicity
Astrobiology
Cancer